Activity and Tolerability of Ibrutinib in Combination With Ofatumumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Titel:
Activity and Tolerability of Ibrutinib in Combination With Ofatumumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Auteur:
Jaglowski, Samantha M. Jones, Jeffrey A. Flynn, Joseph M. Andritsos, Leslie A. Maddocks, Kami J. Woyach, Jennifer A. Blum, Kristie A. Grever, Michael R. Geyer, Susan Michelle Heerema, Nyla A. Lozanski, Gerard Stefanos, Mona Hall, Nathan Nagar, Veena Munneke, Brian West, Jamie-Sue Neuenburg, Jutta K. James, Danelle F. Johnson, Amy J. Byrd, John C.